REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lablink S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Lablink S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Axxis Hospital de Especialidades specializes in clinical and surgical specialties, offering ambulatory medical care, respiratory therapy services, and detailed image diagnostics. They also focus on traumatology, oncology, neurosurgery, and fetal medicine, using advanced technology and innovative techniques for diagnosis and treatment.

Headquarters
Av. 10 de Agosto N39-155, Hospifuturo Bldg.
Quito; Pichincha;

Contact Details: Purchase the Lablink S.A. report to view the information.

Website: http://www.axxishospital.com.ec

Basic Information
Total Employees:
Purchase the Lablink S.A. report to view the information.
Outstanding Shares:
Purchase the Lablink S.A. report to view the information.
Registered Capital:
Purchase the Lablink S.A. report to view the information.
Incorporation Date:
February 10, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
52%
Purchase this report to view the information.
24%
Purchase this report to view the information.
12%
Purchase this report to view the information.
12%
Company Performance
Financial values in the chart are available after Lablink S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.56%▼
Total operating revenue
-2.88%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-27.54%▼
Total assets
21.32%▲
Total equity
54.77%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-3.95%▼
Return on Equity (ROE)
-20.44%▼
Debt to Equity Ratio
-12.86%▼
Quick Ratio
-0.31%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo